ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 16.88 USD 0.06%
Market Cap: 2.8B USD
Have any thoughts about
ACADIA Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
ACADIA Pharmaceuticals Inc

Current Assets 788.3m
Cash & Short-Term Investments 565.3m
Receivables 110.4m
Other Current Assets 112.6m
Non-Current Assets 188.6m
PP&E 48.2m
Intangibles 105.5m
Other Non-Current Assets 34.8m
Current Liabilities 343.9m
Accounts Payable 19.1m
Accrued Liabilities 324.9m
Non-Current Liabilities 55.7m
Other Non-Current Liabilities 55.7m

Balance Sheet
ACADIA Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
62
102
164
69
135
190
326
147
115
189
Cash Equivalents
62
102
164
69
135
190
326
147
115
189
Short-Term Investments
261
113
365
272
339
508
306
373
302
250
Total Receivables
1
2
7
18
28
38
50
65
63
102
Accounts Receivables
0
0
6
17
26
36
48
64
62
98
Other Receivables
0
0
1
1
2
2
2
1
1
4
Inventory
0
0
4
5
4
6
10
8
7
36
Other Current Assets
1
2
8
9
21
19
26
24
21
39
Total Current Assets
325
219
548
374
526
760
718
618
508
616
PP&E Net
1
2
3
3
3
13
56
66
62
56
PP&E Gross
1
2
3
3
3
13
56
66
62
56
Accumulated Depreciation
2
3
3
4
4
5
4
6
8
10
Intangible Assets
0
0
7
6
4
3
1
0
0
65
Other Long-Term Assets
0
1
3
3
7
8
7
16
18
11
Total Assets
326
N/A
222
-32%
561
+153%
385
-31%
540
+40%
783
+45%
783
0%
700
-11%
588
-16%
749
+27%
Liabilities
Accounts Payable
2
2
4
9
3
7
9
7
13
18
Accrued Liabilities
14
20
36
40
56
68
98
89
113
237
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
3
0
0
0
0
0
0
0
Total Current Liabilities
16
22
43
49
60
75
106
96
126
254
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
2
9
50
63
62
63
Total Liabilities
16
N/A
22
+38%
43
+93%
49
+15%
61
+24%
84
+37%
156
+85%
159
+2%
187
+18%
317
+69%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
498
663
934
1 224
1 469
1 704
1 986
2 154
2 370
2 431
Additional Paid In Capital
808
862
1 452
1 559
1 948
2 403
2 613
2 695
2 771
2 863
Other Equity
0
0
0
0
0
0
0
0
1
0
Total Equity
310
N/A
200
-35%
518
+159%
335
-35%
479
+43%
699
+46%
627
-10%
541
-14%
400
-26%
432
+8%
Total Liabilities & Equity
326
N/A
222
-32%
561
+153%
385
-31%
540
+40%
783
+45%
783
0%
700
-11%
588
-16%
749
+27%
Shares Outstanding
Common Shares Outstanding
100
102
121
124
144
155
160
161
162
165
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More